BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1947763)

  • 1. Thyroglobulin in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E
    Scand J Clin Lab Invest Suppl; 1991; 206():79-84. PubMed ID: 1947763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
    Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
    Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
    Harish K
    Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance.
    Fatourechi V; Hay ID
    Semin Nucl Med; 2000 Apr; 30(2):107-14. PubMed ID: 10787191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the detection of serum thyroglobin and I-131 scintigraphy in the follow-up of differentiated thyroid cancer].
    Ruiz Hernández G; Vázquez Forner C; Fliquete Peris MV
    An Med Interna; 2000 Dec; 17(12):642-6. PubMed ID: 11213579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
    Müller-Gärtner HW; Schneider C; Tempel MT
    Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thyroglobulin in differentiated thyroid carcinoma.
    Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
    Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
    Miller JH; Marcus CS
    Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
    Moser E; Fritsch S; Braun S
    Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma.
    Bachelot A; Cailleux AF; Klain M; Baudin E; Ricard M; Bellon N; Caillou B; Travagli JP; Schlumberger M
    Thyroid; 2002 Aug; 12(8):707-11. PubMed ID: 12225639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up of patients with differentiated thyroid cancer: determination of serum thyroglobulin in place of routine 131I scintigraphy?].
    Schatz H; Grebe SF; Horn W; Müller H
    Wien Klin Wochenschr; 1984 May; 96(10):389-93. PubMed ID: 6475061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
    Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
    Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
    Eustatia-Rutten CF; Smit JW; Romijn JA; van der Kleij-Corssmit EP; Pereira AM; Stokkel MP; Kievit J
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):61-74. PubMed ID: 15212646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.
    McDougall IR; Bayer MF
    J Nucl Med; 1980 Aug; 21(8):741-4. PubMed ID: 7400830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.